EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Gaush Meditech's Enterprise Value is HK$2,774.1 Mil.
Gaush Meditech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142.6 Mil. Therefore, Gaush Meditech's EV-to-FCF for today is 19.45.
The historical rank and industry rank for Gaush Meditech's EV-to-FCF or its related term are showing as below:
HKSE:02407'
s EV-to-FCF Range Over the Past 10 Years
Min: 10.56 Med: 19.5 Max: 32.32
Current: 18.95
During the past 5 years, the highest EV-to-FCF of Gaush Meditech was 32.32. The lowest was 10.56. And the median was 19.50.
HKSE:02407's EV-to-FCF is ranked better than 66.12% of 363
companies
in the Medical Devices & Instruments industry
Industry Median: 27.85
vs HKSE:02407: 18.95
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
The historical data trend for Gaush Meditech's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Gaush Meditech's EV-to-FCF
For the Medical Devices subindustry, Gaush Meditech's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Gaush Meditech's EV-to-FCF Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Gaush Meditech's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Gaush Meditech's EV-to-FCF falls into.
Gaush Meditech's current Enterprise Value is HK$2,774.1 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's Free Cash Flow for the trailing twelve months (TTM) ended in Dec. 2023 was HK$142.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Gaush Meditech (HKSE:02407) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Gaush Meditech's PE Ratio for today is calculated as:
Gaush Meditech's share price for today is HK$19.98.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Gaush Meditech's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was HK$1.279.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Gaush Meditech EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Gaush Meditech's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Gaush Meditech Ltd is a provider of a broad spectrum of ophthalmic medical devices. The segments of the company include 1) Proprietary products segment develops and produces surgical equipment and related supporting software, intra-optical lens, ophthalmic disease diagnosis and treatment equipment and related supporting consumables independently; 2) Distribution products segment sells multi-function diagnostic equipment, ocular fundus diagnosis, surgical and treatment equipment and related supporting consumables produced by ophthalmic medical equipment manufacturers; 3) Technical services segment provides warranty services, maintenance services and after-sales services related consumables; and 4) Others segment.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
HKSE:02407 has been successfully added to your